Exploring Differences between US and International Stock-Based Accounting Standards

  • Register
    • Issuer Member - $89
    • Issuer Non-Member - $89
    • Provider/Advisor Member - $89
    • Provider/Advisor Non-Member - $89
    • Academic Member - $89
    • Academic Non-Member - $89
    • Staff Member - $89
    • Non-member - $89

    Continue

It is becoming increasingly common for corporate entities to face dual reporting requirements under US GAAP and IFRS. This imposes the potentially tricky task of maintaining two sets of books related to share-based payment arrangements. This panel of experts have been there and done that—having experienced the challenges companies encounter when navigating through the accounting and administrative complexities involved in dual reporting. Session attendees will learn the key differences in the standards and the operational and administrative traps that are likely to come with them. Throughout the presentation this experienced panel will share “war stories,” lessons learned, and common pitfalls they have encountered, including a lively discussion of the challenges related to an ASC 718/IFRS 2 conversion required as a result of a corporate redomestication, merger, or other transaction. Join this unique session for an insightful look at the challenges of US and international-based accounting standards!
 
Garry Devine, Horizon Pharma plc (US)
Desislava Rosebrock, Actelion Pharmaceuticals Ltd. (CH)
Gregor Sapinsky, SAP (DE)
Ken Stoler, PwC (US)
 

Field of Study: Accounting
Level: II, III
CEP Continuing Education (CE) credit:  .75 hours

Components visible upon registration.